ClinicalTrials.Veeva

Menu

Evaluation of the Sanitary Safety of a Healthcare Professional Conference Held 9-11 June 2021 in Paris (COVID-FREE)

F

French Society for Intensive Care

Status

Completed

Conditions

Covid19

Treatments

Other: Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center)

Study type

Observational

Funder types

Other

Identifiers

NCT04918160
2021-A01185-36

Details and patient eligibility

About

The COVID-SRLF study will evaluate the sanitary safety of the French Intensive Care Society (FICS) annual meeting held in Paris Congress Center from June 9th to June 11th 2021 in the Coronavirus Disease 2019 (COVID-2019) pandemic situation. The primary objective is to determine the proportion of attendees with a positive antigenic COVID-19 screening test at day 7 (+/- 1) of their participation to the meeting. This rate will be compared to a cohort of health care professionals (medical doctors and paramedical professionals) from the same hospital ward as the attendees but who did not attend the meeting (stratified on centers, gender, age (< and >= 40 years, vaccination status (0, 1 or 2 doses) and socio-professional status (medical doctor, nurse, nurse assistant).

Enrollment

711 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthcare professional healthy volunteer
  • Absence of COVID-19 symptoms in the 2 weeks prior to inclusion
  • Not being a COVID-19 contact case in the 2 weeks prior to inclusion
  • Participation to at least one day of the FICS annual meeting (June 9-11 2021)

Exclusion criteria

  • Non-healthcare professional (exhibitors, congress center employees)
  • Refusal to participate to the study
  • Person under legal protection
  • Absence of social security affiliation

Trial design

711 participants in 2 patient groups

Conference Attendees
Description:
Volunteering healthcare practitioners (medical doctor, nurse, nurse assistant, physiotherapist and psychotherapist) attending the FICS annual congress will be proposed to participate to the study. After giving their consent, participants will be asked to perform a COVID-19 antigenic screening self-test at day 7 (+/- 1) of the last day of the meeting (June 11th 2021) and to fill a questionnaire at day 21 of the last day of the meeting (June 11th 2021).
Treatment:
Other: Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center)
Controls
Description:
Volunteering healthcare practitioners (medical doctor, nurse, nurse assistant, physiotherapist and psychotherapist) not attending the FICS annual congress will be proposed to participate to the study. They will be recruited in the same medical departments as the Conference Attendees. After giving their consent, controls will be asked to perform a COVID-19 antigenic screening self-test at day 7 (+/- 1) of the last day of the meeting (June 11th 2021) and to fill a questionnaire at day 21 of the last day of the meeting (June 11th 2021).
Treatment:
Other: Exposure to the FICS annual meeting (June 9-11 2021, Paris Congress Center)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems